Hunan Jiudian Pharmaceuticals Co., Ltd. logo

Hunan Jiudian Pharmaceuticals Co., Ltd. (300705)

Market Open
7 Aug, 06:57
XSHE XSHE
¥
11. 35
+0.42
+3.8426%
¥
8.09B Market Cap
- P/E Ratio
1.25% Div Yield
12.53M Volume
- Eps
¥ 10.93
Previous Close
Add Transaction
Day Range
10.84 11.38
Year Range
9.26 20.66
Want to track 300705 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300705 trading today higher at ¥11.35, an increase of 3.8426% from yesterday's close, completing a monthly increase of 16.6495% or ¥1.62. Over the past 12 months, 300705 stock lost -24.6348%.
300705 pays dividends to its shareholders, with the most recent payment made on May 28, 2026. The next estimated payment will be in In 9 months on May 28, 2027 for a total of ¥0.4.
The last earnings report, released on May 15, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.2347%, based on the last three reports.
Hunan Jiudian Pharmaceuticals Co., Ltd. has completed 3 stock splits, with the recent split occurring on May 24, 2024.
The company's stock is traded on one exchange.

300705 Chart

People also search for

Dr Corp Ltd.
¥ 23.68
-1.0447%
Sunvim Group Co., Ltd.
¥ 11.97
-1.2376%
Tibet Gaozheng Explosive Co., Ltd.
¥ 59
-0.9735%
Innovative Medical Management Co., Ltd.
¥ 21.68
-1.0949%
Henan Liliang Diamond Co., Ltd.
¥ 58.62
-2.3488%

Hunan Jiudian Pharmaceuticals Co., Ltd. (300705) FAQ

What is the stock price today?

The current price is ¥11.35.

On which exchange is it traded?

Hunan Jiudian Pharmaceuticals Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300705.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.25%.

What is its market cap?

As of today, the market cap is 8.09B.

Has Hunan Jiudian Pharmaceuticals Co., Ltd. ever had a stock split?

Hunan Jiudian Pharmaceuticals Co., Ltd. had 3 splits and the recent split was on May 24, 2024.

Hunan Jiudian Pharmaceuticals Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Yang Yang CEO
XSHE Exchange
CNE1000034Z6 ISIN
CN Country
2,221 Employees
28 May 2026 Last Dividend
16 May 2018 Last Split
- IPO Date

Overview

Hunan Jiudian Pharmaceutical Co., Ltd. is a prominent entity in the pharmaceutical industry, engaging in the research, development, production, and sale of various pharmaceutical products in both the local Chinese market and internationally. Since its establishment in 2001, the company has been committed to offering innovative solutions in the medical field. Based in Changsha, China, Hunan Jiudian Pharmaceutical has managed to carve out a reputation for quality and efficacy in its offerings, focusing on a diverse range of therapeutic areas.

Products and Services

Hunan Jiudian Pharmaceutical Co., Ltd. offers an extensive portfolio of products across multiple therapeutic areas. Key products and services include:

  • Loxoprofen Sodium Gel Plaster: A topical pain relief product designed to provide localized relief from muscular and joint pains through the application of a gel plaster. This product showcases the company's commitment to non-invasive pain management solutions.
  • Hydrochloric Acid: Utilized primarily within the realm of other pharmaceutical formulations, indicating Hunan Jiudian Pharmaceutical's involvement in the foundational aspects of drug manufacturing.
  • Anti-inflammatory and Analgesic: The company produces a range of products dedicated to the treatment of inflammation and pain, addressing the needs of patients suffering from conditions that lead to swelling and discomfort.
  • Anti-infective: Recognizing the importance of combating infectious diseases, Hunan Jiudian provides products aimed at inhibiting the spread of pathogens, thereby contributing to global health initiatives against infectious diseases.
  • Anti-allergic: With allergies becoming increasingly common, the company's anti-allergic drugs aim to mitigate allergic reactions, providing relief from the uncomfortable symptoms associated with allergies.
  • Digestive System: Products targeting the digestive tract indicate the company's focus on gastrointestinal health, offering solutions for a variety of digestive disorders.
  • Cardiovascular and Cerebrovascular: Addressing the major global health issue of heart and brain vascular conditions, Hunan Jiudian Pharmaceutical provides medicines aimed at preventing and treating these critical ailments.
  • Gynecological Drugs: Catering to women's health, the company offers specialized pharmaceuticals in the field of gynecology, focusing on treatments for various female health issues.
  • Supplements: Beyond prescription medications, Hunan Jiudian also ventures into health supplements, supporting general wellness and preventive healthcare through nutritional products.

Contact Information

Address: Building A1, Wukuang Lugu Science and Technology Industry Park, Changsha, China, 410205
Phone: 86 731 8822 0222